Wednesday, July 8, 2026

biotech · Hypertension · Essential Hypertension · QNTM

Quantum Pharmaceuticals

Quantum Pharmaceuticals trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.

volkova 6A-1206, Moscow, 141700, RU, CA HQ
2004 Founded
29 Employees
Public company Type
QNTM · NYSE Ticker
Company details
Status
Public
HQ
volkova 6A-1206, Moscow, 141700, RU, CA
Founded
2004
Employees
29
Programs
18
Drugs
17
Patents
36
Intelligence · Clinical Trials

Quantum Pharmaceuticals clinical trials

Registry index of 19 ClinicalTrials.gov studies linked to Quantum Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Quantum Pharmaceuticals trial registry — 19 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Quantum Pharmaceuticals.

  1. QGC001/1QG2 — Phase 1

    Clinical update
  2. Ramipril — Phase 2

    Clinical update
  3. FSD201 — Phase 2

    Clinical update
  4. Symbiotic Formula with DHA and antioxidants — Unknown

    Clinical update
  5. FSD201 — Phase 2

    Clinical update
  6. FSD-F2R6-A-CP — Unknown

    Clinical update
  7. Dendritic Cell Vaccination — Phase 1

    Clinical update
  8. Dendritic Cell Vaccination — Phase 2

    Clinical update

Trial registry

19 studies